Drug Profile
Fentanyl transdermal - Cassava Sciences
Alternative Names: FenrockLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Pain Therapeutics
- Developer Cassava Sciences
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer pain
Most Recent Events
- 27 Mar 2019 Pain Therapeutics is now called Cassava Sciences
- 28 Oct 2018 No recent reports of development identified for preclinical development in Cancer-pain in USA (Transdermal, Patch)
- 26 Sep 2014 Preclinical trials in Cancer pain in USA (Transdermal)